# Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Source: https://onco.cc/trials/nct01700946/  
OnCo record `nct01700946` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Dexamethasone, Vincristine, Rituximab, Clofarabine, Cyclophosphamide, Etoposide, Aldesleukin, Asparaginase, Methotrexate, Mercaptopurine, Cytarabine, Mitoxantrone, Teniposide and Vinblastine in Acute lymphoblastic leukaemia, run by St. Jude Children's Research Hospital, completed.

## Summary

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma is a phase 2 interventional study registered as NCT01700946 by St. Jude Children's Research Hospital, with 80 participants recorded, started 2013-04-15 and reaching its primary completion in 2021-07-24. Interventions recorded: dexamethasone, vincristine sulfate, rituximab, clofarabine, cyclophosphamide, etoposide, aldesleukin, pegaspargase, methotrexate, mercaptopurine, cytarabine, mitoxantrone, teniposide, vinblastine, natural killer cell infusion, laboratory biomarker analysis, therapeutic hydrocortisone, allogeneic hematopoietic stem cell transplantation, CliniMACS. Conditions recorded: Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma.

Linked to the drug Teniposide because the registry names it among its interventions and Acute lymphoblastic leukaemia among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01700946
- Phase: 2
- Setting: A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
- Sponsor: St. Jude Children's Research Hospital
- Enrolled: 80

## Sources

- ClinicalTrials.gov NCT01700946: https://clinicaltrials.gov/study/NCT01700946

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/)
- drugs: [Aldesleukin (high-dose IL-2)](https://onco.cc/drugs/aldesleukin/), [Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase)](https://onco.cc/drugs/asparaginase/), [Clofarabine](https://onco.cc/drugs/clofarabine/), [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Cytarabine](https://onco.cc/drugs/cytarabine/), [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Etoposide](https://onco.cc/drugs/etoposide/), [Mercaptopurine](https://onco.cc/drugs/mercaptopurine/), [Methotrexate](https://onco.cc/drugs/methotrexate/), [Mitoxantrone](https://onco.cc/drugs/mitoxantrone/), [Rituximab](https://onco.cc/drugs/rituximab/), [Teniposide](https://onco.cc/drugs/teniposide/), [Vinblastine](https://onco.cc/drugs/vinblastine/), [Vincristine](https://onco.cc/drugs/vincristine/)

---
JSON: https://onco.cc/api/v1/entities/nct01700946.json